Advanced Pharmaceutical Technology, Inc. recalls TESTO-200
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Marketed Without an Approved NDA/ANDA
- Products
-
- TESTO-200
- Where it was sold
-
NY, NJ
States: New Jersey, New York
- Units affected
- 26 vials
- About this recall
- TESTO-200, Testosterone Cypionate Inj. USP, 2000mg/10ml (200mg/ml), One 10ml multidose vial per carton, For intramuscular injection only, Rx Only, ADVANCED PHARMACEUTICAL TECHNOLOGY, INC., 132 South Central Avenue, Elmsford, NY 10523. NDC 57377-200-01